Caladrius Biosciences Inc

NASDAQ:CLBS  
1.79
-0.03 (-1.65%)
4:45:01 PM EDT: $1.75 -0.04 (-2.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)106.51M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.66 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$1.91
50-Day MA$1.96
200-Day MA$1.89
See more pivots

Caladrius Biosciences, Inc. Stock, NASDAQ:CLBS

110 Allen Road, 2th floor, Basking Ridge, New Jersey 07920
United States of America
Phone: +1.908.842.0100
Number of Employees: 27

Description

Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.